Detail
| LncRNA Name | LINC01296 |
| Synonyms | DUXAP9, LINC01296, FLJ39632, lncRNA-CTD903 |
| Region | GRCh38_14:19062316-19131167 Sequence |
| Ensembl | ENSG00000225210 |
| RefSeq | NA |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | breast cancer |
| ICD-0-3 | C16 |
| Methods | qRT-PCR, Western blot assays, ect. |
| Sample | BC cells (MCF7, MDA-MB-231, SKBR3, BT-20, T47D, MDA-MB-436), and normal mammary epithelial cells (MCF10A), BC tissues and matched adjacent non-tumorous tissue |
| Expression Pattern | up-regulated |
| Function Description | LINC01296 is up-regulated in both BC tissue samples and cells. silencing of LINC01296 inhibited BC cell growth in vitro and in vivo. Also, cell apoptosis was enhanced after LINC01296 silenced. Moreover, cell migration and invasion potential were both abrogated in the si-LINC01296 groups. |
| Pubmed ID | 29981416 |
| Year | 2018 |
| Title | Overexpression of long noncoding RNA LINC01296 indicates an unfavorable prognosis and promotes tumorigenesis in breast cancer. |
| External Links |
| Links for LINC01296 | GenBank HGNC lncrnadb Noncode |
| Links for breast cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.